“Our findings provide more evidence that paracetamol use in infancy may have an adverse effect on respiratory health for children with particular genetic profiles and could be a possible cause of asthma. “There is mounting evidence that the GST superfamily of genes, including three major classes -GSTM1, GSTT1 and GSTP1 – are associated with various diseases, including cancers, asthma, atherosclerosis, allergies, Alzheimer’s and Parkinson’s disease. Our study adds to this body of evidence.”

“Johnson & Johnson Ltd would like to reassure parents and carers that CALPOL® products are the result of decades of experience, research and knowledge. “

“The research presented at a scientific congress followed a group of 620 children, all of whom were potentially at high risk of developing an allergy-related disease.

“The research did not show that taking paracetamol caused children to develop asthma. “Some young children require more paracetamol than others, possibly because they experience more childhood illnesses; it may be these respiratory conditions which cause asthma to develop, not paracetamol use. “CALPOL® is approved for use by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, which continually monitors the safety of medicines in light of emerging evidence.”